Cited by 97Obsessive-Compulsive Spectrum DisordersBody Image and Dysmorphia StudiesHair Growth and Disorders

Comorbidity and quality of life in adults with hair pulling disorder

Open access
Houghton, David C., Maas, Joyce, Twohig, Michael P., Saunders, Stephen M., Compton, Scott N., Neal-Barnett, Angela M., Franklin, Martin E., Woods, Douglas W.·2016·Psychiatry Research

Abstract

Hair pulling disorder (HPD; trichotillomania) is thought to be associated with significant psychiatric comorbidity and functional impairment. However, few methodologically rigorous studies of HPD have been conducted, rendering such conclusions tenuous. The following study examined comorbidity and psychosocial functioning in a well-characterized sample of adults with HPD (N=85) who met DSM-IV criteria, had at least moderate hair pulling severity, and participated in a clinical trial. Results revealed that 38.8% of individuals with HPD had another current psychiatric diagnosis and 78.8% had another lifetime (present and/or past) psychiatric diagnosis. Specifically, HPD showed substantial overlap with depressive, anxiety, addictive, and other body-focused repetitive behavior disorders. The relationships between certain comorbidity patterns, hair pulling severity, current mood and anxiety symptoms, and quality of life were also examined. Results showed that current depressive symptoms were the only predictor of quality of life deficits. Implications of these findings for the conceptualization and treatment of HPD are discussed. © 2016 Elsevier Ireland Ltd.

Integrity signals

Registry

Crossref · 10.1016/j.psychres.2016.02.063

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 9 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Among the variables examined, only BDI scores were significantly correlated with QOLI scores.

    “Only BDI scores were significantly correlated with the QOLI.”
    Quote in the paperSubstantial claim
  • Findingown data

    The HPD sample showed substantial comorbidity with depressive, anxiety, addictive, and other body-focused repetitive behavior disorders.

    “Specifically, HPD showed substantial overlap with depressive, anxiety, addictive, and other body-focused repetitive behavior disorders.”
    Quote in the paperSubstantial claim
  • Findingown data

    The average quality-of-life t-score was near the upper end of the low range (mean 41.2, SD 14.7).

    “The average Quality of Life t-score was near the upper bound of the low range (M = 41.2, SD = 14.7).”
    Quote in the paperNot a substantial claim
  • Findingown data

    The current study's lifetime comorbidity rate for GAD was 14.1%, versus a previous-study average of 25.6%.

    “Additionally, notable differences for our data and the average lifetime comorbidity rates from previous studies were on Excoriation Disorders (12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs. 12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs. 8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%).”
    Quote in the paperNot a substantial claim
  • Findingown data

    In the same sample, 78.8% had a lifetime (current or past) additional psychiatric diagnosis.

    “Results revealed that 38.8% of individuals with HPD had another current psychiatric diagnosis and 78.8% had another lifetime (present and/or past) psychiatric diagnosis.”
    • Also stated in: § 3.2. Comorbidity · plain
      “According to the SCID-P (Table 4), the majority of patients (78.8%) met criteria for at least one lifetime comorbid psychiatric condition, and 38.8% were determined to be currently suffering from another Axis I disorder.”
    Quote in the paperNot a substantial claim
  • May combine two claims. 11
  • Classified as probably not a substantial claim. 1
  • May combine two claims.

    Findingown data

    The current study's current comorbidity rate for Excoriation Disorder was 12.9%, versus a previous-study average of 21.6%.

    “The most notable differences between data from this study and average current comorbidity rates from previous studies (See Tables 2, 3, and 4; current study data reported first) were on Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs. 17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The current study's current comorbidity rate for OCD was 4.7%, versus a previous-study average of 9.3%.

    “The most notable differences between data from this study and average current comorbidity rates from previous studies (See Tables 2, 3, and 4; current study data reported first) were on Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs. 17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The current study's current comorbidity rate for Major Depression was 3.5%, versus a previous-study average of 17.1%.

    “The most notable differences between data from this study and average current comorbidity rates from previous studies (See Tables 2, 3, and 4; current study data reported first) were on Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs. 17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Mean BDI and BAI scores were in the minimal-to-mild range (12.92, SD 10.19; 13.35, SD 13.25), with large standard deviations.

    “Mean BDI and BAI scores were in the minimal to mild range at 12.92 (SD = 10.19) and 13.35 (SD = 13.25), respectively, and both had large standard deviations.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The current study's lifetime comorbidity rate for OCD was 7.1%, versus a previous-study average of 15.3%.

    “Additionally, notable differences for our data and the average lifetime comorbidity rates from previous studies were on Excoriation Disorders (12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs. 12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs. 8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    The current study's lifetime comorbidity rate for Alcohol Abuse Disorder was 17.7%, versus a previous-study average of 8.9%.

    “Additionally, notable differences for our data and the average lifetime comorbidity rates from previous studies were on Excoriation Disorders (12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs. 12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs. 8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation

    Persons with HPD in this study reported quality of life in the upper part of the low range, similar to three previous studies using the same measure (QOLI means 41.20 vs 43.00, 44.31, 42.77).

    “In this study, persons with HPD reported quality of life in the upper part of the low range, which was very similar to that reported by three previous studies utilizing the same measure (Raw score means on the QOLI = 41.20 vs. 43.00, 44.31, 42.77; Diefenbach et al., 2005b; Odlaug et al., 2010; E. Tung, personal communication, October 4, 2015).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Diefenbach et al., 2005b

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Odlaug et al., 2010 source
    • cites E. Tung, personal communication, October 4, 2015

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Findingown data

    The most frequent current comorbid conditions were Excoriation Disorder and Generalized Anxiety Disorder, followed by Specific Phobia and Obsessive-Compulsive Disorder.

    “The most common current comorbid conditions were Excoriation Disorder and Generalized Anxiety Disorder, followed by Specific Phobia and Obsessive-Compulsive Disorder.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductcitation

    The QOLI contains no question regarding appearance, which can be particularly relevant for persons with HPD.

    “As noted by Odlaug et al. (2010), although the QOLI assesses a range of topics including self-esteem, it contains no question regarding appearance, which can be particularly relevant for persons with HPD.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Odlaug et al. (2010) source
  • May combine two claims.

    Study design and conductcitation

    All individuals in the current study were seeking treatment for HPD, which could result in an over-estimation of the amount of comorbidities.

    “A related concern is that all individuals in the current study were seeking treatment for HPD, which could result in an over-estimation of the amount of comorbidities, as these persons are more likely to seek help (Alexander et al., 1986).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Alexander et al., 1986

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationcitation

    The rate of Excoriation disorder in this study might be below average but not outside the range of other studies (10-34%, average 20.8%).

    “Differences in the rates of Excoriation Disorder between our study and that of Tung et al. (2015) might seem large, but a review by Snorrason et al. (2012) showed that comorbidity rates between HPD and Excoriation fall between 10 to 34% (average = 20.8%). Thus, our rate of Excoriation disorder might be below average, but not outside the range of other studies.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Snorrason et al. (2012) source
    • cites Tung et al. (2015) source
  • May combine two claims.

    Study design and conductreasoning

    The variable correlating significantly with quality of life, depression, was measured continuously and allowed to vary freely, whereas some other variables were constrained by inclusion criteria (MGH ≥ 12), which could have attenuated the correlation between hair pulling severity and quality of life.

    “It must, however, be noted that the variable correlating significantly with quality of life, depression, was measured continuously and allowed to freely vary, whereas some other variables were constrained due to inclusion criteria (i.e., MGH ≥ 12). This practice could have attenuated the correlation between hair pulling severity as measured by the MGH.”
    Quote in the paperSubstantial claim
12 of 12
  • The paper relies on this without support.

    Current depressive symptoms causally reduce quality of life in HPD, rather than merely correlating with it.

    “Data from the current study suggest SSRIs may help improve QOL by reducing depressive symptoms, even if the medications do little to the pulling symptoms.”
  • The paper relies on this without support.

    Despite selection bias from screening out some comorbidities and using a treatment-seeking sample, the study's comorbidity and quality-of-life findings are sufficiently informative about HPD to contribute to the literature.

    “These caveats notwithstanding, this study contributes substantially to the existing literature regarding comorbidity patterns in HPD.”
2 of 2

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Specific phobia cannot rank ahead of major depression among current diagnoses

    Minor

    Specific Phobia is listed among the most common current conditions, but its lifetime rate is only 2.4%, so its current rate cannot exceed 2.4%. The reported current Major Depression rate is 3.5%.

  • Quality-of-life mean is labeled both a t-score and a raw score

    Minor

    The results identify 41.2 as the mean QOLI t-score, but the discussion identifies the same study mean, 41.20, as a raw score.

2 of 2

Cites

Flagged first, then by citations

4 of the 67 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Christenson, 1995, Trichotillomania: from prevalence to comorbidity, Psychiatry Times, 44

Cited by

Sorted by citations

Authors
Houghton, D. C., Maas, J., Twohig, M. P., Saunders, S. M., Compton, S. N., Neal-Barnett, A. M., Franklin, M. E., & Woods, D. W.
Affiliations
  • Texas A&M University (US)
  • Radboud University Nijmegen (NL)
  • Utah State University (US)
  • Marquette University (US)
  • Duke University (US)
  • Kent State University (US)
  • University of Pennsylvania (US)
Corresponding author
Woods, Douglas W.
Venue
Psychiatry Research
Publisher
Elsevier BV
Published
2016-05
Volume
239
Pages
12-19
ISSN
0165-1781 (ISSN-L)
OpenAlex
W2289915271
Cited by
97
References
67
Citations by year
2026: 5 · 2025: 9 · 2024: 5 · 2023: 34 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 3
FWCI
12.48
Type
journal article
Language
en
Open access
Locations
  • Psychiatry Research (publishedVersion)
  • Research portal (Tilburg University) (publishedVersion)
  • Tilburg University Research Portal (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • e-Publications@Marquette (Marquette University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
NIMH (R01MH080966)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Social Sciences › Psychology › Clinical Psychology › Body Image and Dysmorphia Studies
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
Keywords
trichotillomania, psychiatric comorbidity, quality of life, depressive symptoms, anxiety symptoms, addiction, body-focused repetitive behaviors, psychosocial functioning, adults
MeSH terms
Adult, Anxiety, Depression, Female, Humans, Male, Middle Aged, Quality of Life, Trichotillomania, Comorbidity, Diagnostic and Statistical Manual of Mental Disorders, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read under definition version 3 (extract-v3) on 2026-09-28.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review